Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2026)

Lantheus Holdings (LNTH) reported Depreciation & Amortization (CF) of $22.7 million for Q1 2026, up 66.47% year-over-year from $13.6 million in Q1 2025, and down 0.66% quarter-over-quarter from $22.8 million in Q4 2025.

Lantheus Holdings (LNTH) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $22.7 million in Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $22.7 million, up 66.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.2 million (up 26.03% YoY), and the FY2025 annual result was $70.1 million, up 8.47% from the prior year.
  • Depreciation & Amortization (CF) retreated to $22.7 million in Q1 2026 per LNTH's latest filing, from $22.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $22.8 million in Q4 2025 and troughed at $11.8 million in Q1 2022.
  • A 5-year average of $15.6 million and a median of $14.8 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) retreated 11.78% in 2025, then soared 66.47% in 2026.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $11.9 million in 2022, then climbed by 26.38% to $15.0 million in 2023, then rose by 15.12% to $17.3 million in 2024, then jumped by 32.1% to $22.8 million in 2025, then fell by 0.66% to $22.7 million in 2026.
  • Business Quant data shows LNTH's Depreciation & Amortization (CF) at $22.7 million in Q1 2026, $22.8 million in Q4 2025, and $20.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 239.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 19.43 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 22.68 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 21.95 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 497,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 22.68 Mn
Mar 31, 2026 22.68 Mn
Dec 31, 2025 22.83 Mn
Dec 31, 2025 22.83 Mn
Sep 30, 2025 20.41 Mn
Sep 30, 2025 20.41 Mn
Jun 30, 2025 13.23 Mn
Jun 30, 2025 13.23 Mn
Mar 31, 2025 13.63 Mn
Mar 31, 2025 13.63 Mn
Dec 31, 2024 17.29 Mn
Dec 31, 2024 17.29 Mn
Sep 30, 2024 17.08 Mn
Sep 30, 2024 17.08 Mn
Jun 30, 2024 14.82 Mn
Jun 30, 2024 14.82 Mn
Mar 31, 2024 15.45 Mn
Mar 31, 2024 15.45 Mn
Dec 31, 2023 15.02 Mn
Dec 31, 2023 15.02 Mn